Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.


Clinical Trial Description

To demonstrate the safety and effectiveness of primary Left Ventricular unloading and a thirty-minutes delay to reperfusion vs. current standard of care in reducing infarct size and heart failure-related clinical events in patients presenting with anterior ST-Elevation Myocardial Infarction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03947619
Study type Interventional
Source Abiomed Inc.
Contact Poornima Sood, MD, MBA
Phone 978-882-8494
Email psood@abiomed.com
Status Recruiting
Phase N/A
Start date December 12, 2019
Completion date October 2030

See also
  Status Clinical Trial Phase
Completed NCT02071602 - CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Phase 1